Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease
Clinical trial NCT03201445 · TERMINATED
Trial details
- NCT number
- NCT03201445
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-11
- Primary completion
- 2020-11-20
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.